This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abbexa
product type :
ELISA/assay
product name :
Human Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) ELISA Kit
catalog :
abx386045
quantity :
96 tests
product information
Catalogue Code :
abx386045
Target :
Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22)
Product Name :
Human Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) ELISA Kit
Short Name :
BHLHE22
Category :
ELISA Kits
Size 1 :
96 tests
Size 2 :
5 × 96 tests
Size 3 :
10 × 96 tests
Description :
Human Class E Basic Helix-Loop-Helix Protein 22 (BHLHE22) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Basic Helix Loop Helix Family, Member e22 (BHLHE22) concentrations in tissue homogenates, cell lysates and other biological fluids.
UniProt Primary AC :
Q8NFJ8
UniProt Entry Name :
BHE22_HUMAN
Gene Symbol :
BHLHE22
OMIM :
613483
HGNC :
11963
KEGG :
hsa:27319
Ensembl :
ENSG00000180828
String :
9606.ENSP00000318799
Tested Applications :
ELISA
Storage :
Shipped at 4 °C. Upon receipt, store the kit according to the storage instruction in the kit's manual.
UNSPSC Code :
41116158
Availability :
Shipped within 5-12 working days.
DryIce :
No
company information
Abbexa
Abbexa LTD, Cambridge, UK
Abbexa LLC, Houston, USA
Abbexa LLC, Houston, USA
info@abbexa.com
https://www.abbexa.com44 (0)1223 75595
1 832 327 7413
1 832 327 7413
headquarters: UK
Abbexa is a biotechnology company based in Cambridge, UK, specializing in high quality, reliable research reagents for scientific research. We work in partnership with academic institutions, hospitals and laboratories across the world to bring an integrated source of antibodies, proteins, ELISA kits and other biological reagents. We are dedicated to providing excellent customer service, quality and affordable products to enable scientists to do better science. For more information, please visit http://www.abbexa.com/.
questions and comments